Mr Sabin Dolino, | |
6411 Fannin St, Houston, TX 77030-1501 | |
(713) 704-4000 | |
Not Available |
Full Name | Mr Sabin Dolino |
---|---|
Gender | Male |
Speciality | Anesthesiology Assistant |
Experience | 6 Years |
Location | 6411 Fannin St, Houston, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336649136 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Secondary |
367H00000X | Anesthesiologist Assistant | 24570602 (* (Not Available)) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ut Physicians | 8426960360 | 1400 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | Ut Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | Medical Anesthesia Associates, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104868686 PECOS PAC ID: 8022002823 Enrollment ID: O20040414000079 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | North Medical Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659745693 PECOS PAC ID: 9739480310 Enrollment ID: O20160210001739 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | Independent Physicians Network Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396274676 PECOS PAC ID: 5496029407 Enrollment ID: O20170914001408 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | Dynamic Anesthesia Providers, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346752326 PECOS PAC ID: 0547529596 Enrollment ID: O20180119000344 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Entity Name | Compass Anesthesia Providers, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669829750 PECOS PAC ID: 4082040878 Enrollment ID: O20200217000123 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Sabin Dolino, 8181 Fannin St Apt 1217, Houston, TX 77054-2920 Ph: (281) 787-4672 | Mr Sabin Dolino, 6411 Fannin St, Houston, TX 77030-1501 Ph: (713) 704-4000 |
News Archive
JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).
Lupin Pharmaceuticals Inc., the U.S. wholly owned subsidiary of Lupin Limited, dedicated to delivering high-quality medications trusted by healthcare professionals and women across many treatment areas, has partnered with the National Association of Nurse Practitioners in Women's Health to conduct a national online survey of 301 HCPs (including OB/GYNs and NP/PAs) who treat women with bacterial vaginosis (BV).
Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.
"More than two million people in Sudan's Darfur region will be vaccinated against a rare yellow fever outbreak suspected of killing 107 people since late September, health officials said on Tuesday," Agence France-Presse/France 24 reports (11/13). In a joint statement, the WHO and the Sudanese Ministry of Health said the mosquito-borne disease has spread throughout the western territory, which "has been plagued by conflict since rebels took up arms in 2003," Reuters notes.
In this article, "IRIN took a look at some of the push and pull factors behind health worker migration, and what countries are doing to address them."
› Verified 1 days ago
James Nast Trahan, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 713-620-4000 | |
Caitlyn Marie Kohake, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 823-355-2666 | |
Robert Sean Mcneill, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 | |
Aleena A Gillani, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 972-233-1999 Fax: 972-233-3666 | |
Logan Patrick Fettig, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 832-355-2666 | |
Joseph Grant Shafer, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6414 Fannin St, #g125, Houston, TX 77030 Phone: 713-500-6930 Fax: 713-500-5484 | |
Sarah P Her, AA-S Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 |